167 related articles for article (PubMed ID: 35977459)
41. Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff.
Aronson ID; Bennett AS; Freeman R
Harm Reduct J; 2020 Oct; 17(1):77. PubMed ID: 33076911
[TBL] [Abstract][Full Text] [Related]
42. An Early Implementation Analysis of Syringe Services Programs in Kentucky: Barriers and Facilitators Identified by Program Operators and Local Officials.
Harris SJ
AIDS Behav; 2023 Apr; 27(4):1248-1258. PubMed ID: 36318428
[TBL] [Abstract][Full Text] [Related]
43. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020.
Tookes HE; Bartholomew TS; Sugar SES; Plesons MD; Bluthenthal RN; Wenger LD; Patel SV; Kral AH; Lambdin BH
Int J Drug Policy; 2024 Jan; 123():104289. PubMed ID: 38071932
[TBL] [Abstract][Full Text] [Related]
44. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.
Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL
Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493
[TBL] [Abstract][Full Text] [Related]
45. "They don't go by the law around here": law enforcement interactions after the legalization of syringe services programs in North Carolina.
Morrissey B; Hughes T; Ostrach B; Wilson L; Getty R; Combs TL; Bennett J; Carroll JJ
Harm Reduct J; 2022 Sep; 19(1):106. PubMed ID: 36163255
[TBL] [Abstract][Full Text] [Related]
46. Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection supplies.
Hayes BT; Favaro J; Coello D; Behrends CN; Jakubowski A; Fox AD
Int J Drug Policy; 2022 Jan; 99():103474. PubMed ID: 34619446
[TBL] [Abstract][Full Text] [Related]
47. Early disruptions to syringe services programs during the Russian invasion of Ukraine.
Nikitin BM; Bromberg DJ; Pykalo I; Ivasiy R; Islam Z; Altice FL
Front Public Health; 2023; 11():1229057. PubMed ID: 38074770
[TBL] [Abstract][Full Text] [Related]
48. Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia.
Allen ST; Mazhnaya A; O'Rourke A; White RH; Wedlock P; Grieb SM; Kilkenny ME; Walls M; Sherman SG
Subst Use Misuse; 2021; 56(12):1776-1784. PubMed ID: 34311667
[TBL] [Abstract][Full Text] [Related]
49. Health service utilisation and access for people who inject drugs during COVID-19.
Efunnuga H; Higgs P; Walker S; O'Keefe D
Drug Alcohol Rev; 2022 Sep; 41(6):1304-1310. PubMed ID: 35266229
[TBL] [Abstract][Full Text] [Related]
50. Distributive Syringe Sharing and Use of Syringe Services Programs (SSPs) Among Persons Who Inject Drugs.
Adams M; An Q; Broz D; Burnett J; Wejnert C; Paz-Bailey G;
AIDS Behav; 2019 Dec; 23(12):3306-3314. PubMed ID: 31512066
[TBL] [Abstract][Full Text] [Related]
51. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
[TBL] [Abstract][Full Text] [Related]
52. Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study.
Goedel WC; King MRF; Lurie MN; Galea S; Townsend JP; Galvani AP; Friedman SR; Marshall BDL
Clin Infect Dis; 2020 Mar; 70(6):1096-1102. PubMed ID: 31143944
[TBL] [Abstract][Full Text] [Related]
53. Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis.
Bartholomew TS; Tookes HE; Bullock C; Onugha J; Forrest DW; Feaster DJ
Int J Drug Policy; 2020 Apr; 78():102716. PubMed ID: 32146348
[TBL] [Abstract][Full Text] [Related]
54. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
[TBL] [Abstract][Full Text] [Related]
55. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
[TBL] [Abstract][Full Text] [Related]
56. NEXT: description, rationale, and evaluation of a novel internet-based mail-delivered syringe service program.
Hayes BT; Favaro J; Behrends CN; Coello D; Jakubowski A; Fox AD
J Subst Use; 2024; 29(1):129-135. PubMed ID: 38577252
[TBL] [Abstract][Full Text] [Related]
57. Syringe services programs: An examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S.
Jones CM
Int J Drug Policy; 2019 Aug; 70():22-32. PubMed ID: 31059965
[TBL] [Abstract][Full Text] [Related]
58. Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.
Lindqvist K; Wallmofeldt C; Holmén E; Hammarberg A; Kåberg M
Harm Reduct J; 2021 May; 18(1):52. PubMed ID: 33971892
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
60. Injection Behaviors and Use of Syringe Service Programs over Time among People Who Inject Drugs in Baltimore, Maryland.
German D; Glick JL; Yenokyan K; Genberg B; Sawyer A; Gribbin M; Flynn C
Subst Use Misuse; 2024; 59(5):651-664. PubMed ID: 38115628
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
